Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Actually Rnva remembered me when I bought LDSR late Oct., 2017 at 0.0001 and sold it at 0.0003 next month, with a gain of 200%, then it skyrocketed to 0.0266 in just 3 months on Feb., 2018.
Be careful longs, not to sell at 3 or 5 or 10
GLTA
I think it’s so clear now that management plan is to announce the RS 1:10,000 on Friday Sep.27 after market close to sell more shares at .0002 during next week before trading post split at $1 on Monday Sep.30, then dilution machine will start again, and price will return back to 0.0001 after 2 months like previous split
RS 1:10000 will announce tomorrow after market with effect of trading post split on Friday Sep.13, 2019
Good luck to all
Last chance to steal shares at this low level before buying over 0.01 on Wednesday after release quarter results
62M shares was traded on Friday, the highest volume since June 28, 2018 when traded 85M shares at 0.07
Big news on the way, last opportunity to buy at these low levels
I think buying at this level is like a steal.
This week with Q results and huge news, Celz will skyrocketing to higher levels, maybe more than 0.01
Good luck longs
Last chance to buy at this level, like a steal
IMO 0.0013 is the bottom, the trip to .07 and above is starting now
Good luck longs
No man, sure there will be a run after RS, but to the down side to 0.0001 again, just take a look to the previous RS.
You’re right, after RS 1:10000, pps will be $1, then dilution machine will start again and pps will go to 0.0001 again, picture is so clear guys. The formula is so easy, divide your shares worth now by 10000 to know what’s your shares worth post split.
After dilution finished , and the OS will be 10B, doing RS 1:10000, the OS will be 1M, and the AS 10B, then same scenario, dilution another 9.999B shares. Picture is so clear, without this scenario, RNVA can’t continue it’s operations.
No RS, there are many companies with OS and AS over 1B, and not done RS
No man, you aren’t crazy, just be patient and you will sell your shares at pps 0.05 or more.
Celz is under huge accumulation by MM’s, they want everyone to sell their shares at this low price then they will skyrocketing pps in any day during the next weeks
Just wait and you will see that I’m right
Remember Celz last year when it was 0.0023 on Mar 23, 2018, and skyrocketed to 0.07 on June 28, 2018, yes, 30X in just 3 months without any news or revenues, not like this days
RS was approved, what is management waiting for? Let’s do it, maybe there’s a little hope with this ridiculous stock
Don’t look to anyone case, look to my case, I had 125000 shares before previous RS1:250 last July with a cost of $25000, I bought it at $0.20, then my shares became 500 shares after RS at 0.0025 now with a market of just $1.25, and still you told existing shareholders not to sell.
It will happen same as previous RS, it will open at $2.50 after RS 1:1000, then dilution starting and dropping to sub penny again, since AS is 2B, there is a room to dilute another 1.998B shares.
Existing shareholders must sell their shares on Monday to keep their losses limited.
I totally agree with you, CELZ pps should be in dollars not pennies due to its bright future and promising product, but my only fear if management think to reverse splitting its shares, since OS now is over 1B shares, this would destroy the existing shareholders
IMO, CELZ will be a target before end of this year for one of the biggest drugs company with a deal not below 200M. CELZ has a unique product and promising revenues.
The management will take share price up to at least 0.10 in the next 2-3 months
Where’s the boxes cover2?
I’m long on Celz since last year, but with all good news released recently, and stock price not going up, I think shorts are right, and stock price will go down big in the next weeks, maybe reach 0.0020, remember that Celz was 0.0021 before skyrocketed to 0.07 last year.
Sorry longs, but this the truth, and I will sell all my shares tomorrow. Glta
Anybody knows when will be the voting day, please advise. Thanks
I wish we were still in 2016, at least Rnva market cap was more than $50M not as now 300k
I totally agree with you, I think Rnva will up hugely to at least $1, but when doing RS 1:10000
Just take a look to the bright future of this company, there are a lot of companies in OTC market with a market cap over 100M without any revenues or future. Even in Nasdaq, look at Tesla company, EPS negative and stock price over $200. Investors always look at the future of the company. I told you, just watch CELZ stock price in the next six months.
I think buying at this level like a robbery
You are right, but at any situation CELZ will not stay at a market cap of 10M. This is at least a 100M market cap.
Next months will prove that for you
No problem, sell all of your shares on Monday, but remember when CELZ skyrocketed last year from 0.0110 on May 25 ,2018 to 0.07 on June 28, 2018 in just one month. Also remember when CELZ skyrocketed last year from 0.0023 on Mar.22 ,2018 to 0.0157 on Mar.27 ,2018 in just five days. It was up without revenues or news, look to revenues or huge news nowadays, CELZ will skyrocketing to a level which no one can be predicted, IMO CELZ will reach 50 cents or $1 within the next 6 months.
Just mark my post
I know that there’s a light at the end of the tunnel, but the main issue with this stock is dilution and RS, if you have 5M now at 0.0036 with a cost of $18000, you will have just 5000 shares after 1:1000 at $3.60, and when dilution start, the price will go to penny area again, you will loose more than 95% of your investment. Just take a look at what happened on July 25, 2018 when HMNY have done 1:250 RS, it closed at 0.08 on July 24, 2018, opened at $20 after RS, reached 0.0150 after just one month on Aug.24 ,2018
IMO, RS is on the way. The company needs money to go with its operations, and no way to continue without dilution and RS.
This is all that matters.......but don't trust me or anyone on the blog. Do you own DD please. The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures. CaverStem has been shown to be effective even in patients who do not respond to PDE5 inhibitors. CaverStem is safe. Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy. CELZ added physicians in Hawaii (Sanderson), California, Ohio, Texas and Tennessee (to be named soon) and CELZ will continually add the new physicians to the CaverStem™ website as they come aboard. To speed up new physician training due to demand, CELZ added additional medical personnel to travel to each physicians office to train. Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative. Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria. CaverStem has begun a series of mailer and email campaigns introducing the CaverStem procedure to licensed physicians in the areas of urology, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CaverStem reported good replies from the January emails. CaverStem has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area. U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia. Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction. A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14 Please review this. CELZ is working on their paper for publication. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only. Revenue has now started, CMTH is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CMTH anticipates reaching financial self-sufficiency by revenues from sales in 2019. CMTH has Institutional Investors now, slowing dilution and providing much better terms as CMTH completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations. CaverStem signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem will generate. This has generated many calls to the vetted doctors. CMTH has started commercializing and scheduling patients for the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program. CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStemTM and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem and FemCelz brands. CaverStem and FemCelz are just TWO of SEVERAL patents held by CMTH. 4 NEW patents were applied for in 2018. Gershman and Ichim have already successfully commercialized Medistem. CaverStem, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED CaverStem is now a REGISTERED TRADEMARK. Caverstem® We KNOW Caverstem® + FemCelz + StemSpine + AmnioStem = NASDAQ PLEASE
Report TOS
I totally agree with you, I will wait another one or more years, but my only fear is dilution, because dilution leads to more OS, and more OS leads to RS, and RS is ugly for existing shareholders.
I had bad experience with RS, with DCTH & RNVA
Thanks for your posts, much appreciated, I’m long on Celz with a good position, but I’m just afraid that Celz will do reverse splitting in the coming months, since OS now is around 1.3 B shares. I know that many will tell me that our Ceo have around 80M shares, and it’s impossible to approve this, but management needs money on a monthly basis to go through their activities, and needs to make more dilution to gets money, and reverse splitting will help, I hope I’d be wrong in my thought, since RS always bad for existing shareholders, I had a bad experience in RS of two stocks DCTH and HMNY.
Thanks again for your great analysis.
Actually, I’m long on Celz, but as I saw no any move to the upside today with a huge jump in cash and revenues, sorry to say, we are on the way to go down from here, maybe to 0.0050 area before any reverse to the upside if Q1 which will release in May have a great news related to revenues. Many sites downgraded the stock today. GLTA
https://www.americanbulls.com/m/SignalPage.aspx?lang=en&Ticker=CELZ
IMO, today is your day Celz’ers
The uptrend is starting today, and you all to be rich in just 2 months, Celz is on its way to go to 0.30
GLTA
Celz engine will start at 2:30pm, will close over 0.0120, just watch
You need more predictions bro, ok
Tomorrow you will see a double digits volume with closing around 0.0125, and once it’s crossed 0.0128 level, no resistance until 0.0155
Exactly as I predicted in the morning, Celz is starting it’s journey to the moon.
GLTA